2 weeks Ago By ABMN Staff
Curaleaf Holdings, Inc. ( OTCMKTS:CURLF – Free Report ) – Equities researchers at Roth Capital issued their FY2024 earnings per share estimates for shares of Curaleaf in a note issued to investors on Sunday, November 10th. Roth Capital analyst W.
Kirk anticipates that the company will earn ($0.26) per share for the year. Roth Capital currently has a “Strong-Buy” rating on the stock.
The consensus estimate for Curaleaf’s current full-year earnings is ($0.25) per share. Roth Capital also issued estimates for Curaleaf’s Q4 2024 earnings at ($0.
07) EPS, Q1 2025 earnings at ($0.06) EPS, Q2 2025 earnings at ($0.06) EPS, Q3 2025 earnings at ($0.
05) EPS, Q4 2025 earnings at ($0.04) EPS and FY2025 earnings at ($0.21) EPS.
Several other research firms also recently weighed in on CURLF. Needham & Company LLC restated a “buy” rating and set a $6.25 target price on shares of Curaleaf in a report on Thursday, August 8th.
Cormark lowered shares of Curaleaf from a “moderate buy” rating to a “hold” rating in a research report on Thursday, November 7th. Curaleaf Stock Down 1.8 % Curaleaf stock opened at $2.
20 on Wednesday. The firm has a market capitalization of $1.43 billion, a price-to-earnings ratio of -7.
59 and a beta of 0.86. The company has a debt-to-equity ratio of 0.
85, a quick ratio of 0.51 and a current ratio of 1.11.
Curaleaf has a fifty-two week low of $1.64 and a fifty-two week high of $6.40.
The stock’s fifty day moving average is $2.90 and its two-hundred day moving average is $3.72.
Curaleaf Company Profile ( Get Free Report ) Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Featured Articles Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter ..
